FDA proposes to exclude semaglutide, tirzepatide from compounding list
Go back to FDA proposes to exclude semaglutide, tirzepatide from compounding list| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1210.02 -10.64 (0.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1220.66 | 52 Week High | $88.16 | |||
| Open | $1215.18 | 52 Week Low | $67.88 | |||
| Day High | $1229.19 | P/E | 280.10 | |||
| Day Low | $1204.80 | EPS | $4.32 | |||
| Volume | 2,172,851 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 51.58 +0.62 (1.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.96 | 52 Week High | $59.00 | |||
| Open | $51.00 | 52 Week Low | $32.80 | |||
| Day High | $52.12 | P/E | N/A | |||
| Day Low | $50.92 | EPS | $0.00 | |||
| Volume | 8,709,110 | |||||

